Skip to main content
. 2019 Feb 6;26(2):143–154. doi: 10.1177/1526602819827295

Table 4.

Procedure and Lesion Success Outcome Measures.a

Baseline RC
p
RC2,3; 486 subjects, 605 lesionsb RC4,5; 571 subjects, 775 lesionsb RC6; 98 subjects, 148 lesionsb RC2,3 vs RC4,5 RC2,3 vs RC6 RC4,5 vs RC6
Procedure success 392/469 (83.6) [79.9 to 86.8] 413/545 (75.8) [72.0 to 79.3] 63/92 (68.5) [58.0 to 77.8] 0.002 0.001 0.15
Final residual stenosis <50% in all lesions 425/469 (90.6) [87.6 to 93.1] 456/546 (83.5) [80.1 to 86.5] 72/94 (76.6) [66.7 to 84.7] 0.001 <0.001 0.11
Significant angiographic complications 41/483 (8.5) [6.2 to 11.3] 66/566 (11.7) [9.1 to 14.6] 14/95 (14.7) [8.3 to 23.5] 0.10 0.08 0.40
 Severe dissection (C-F) 13/485 (2.7) [1.4 to 4.5] 17/569 (3.0) [1.7 to 4.7] 6/98 (6.1) [2.3 to 12.9] 0.85 0.11 0.13
 Perforation 6/485 (1.2) [0.5 to 2.7] 4/569 (2.5) [1.4 to 4.1] 2/98 (2.0) [0.2 to 7.2] 0.18 0.63 >0.99
 Abrupt closure 4/485 (0.8) [0.2 to 2.1] 13/569 (2.3) [1.2 to 3.9] 3/98 (3.1) [0.6 to 8.7] 0.08 0.10 0.72
 Distal embolization 21/482 (4.4) [2.7 to 6.6] 31/566 (5.5) [3.8 to 7.7] 5/95 (5.3) [1.7 to 11.9] 0.48 0.60 >0.99
Lesion success 491/578 (84.9) [81.8 to 87.8] 580/733 (79.1) [76.0 to 82.0] 106/141 (75.2) [67.2 to 82.1] 0.007 0.01 0.36
Final residual stenosis <50% 533/580 (91.9) [89.4 to 94.0] 636/733 (86.8) [84.1 to 89.1] 119/143 (83.2) [76.1 to 88.9] 0.003 0.003 0.32
Significant angiographic complications 47/600 (7.8) [5.8 to 10.3] 78/771 (10.1) [8.1 to 12.5] 18/144 (12.5) [7.6 to 19.0] 0.15 0.07 0.33
 Severe dissection (C-F) 13/604 (2.2) [1.2 to 3.7] 18/773 (2.3) [1.4 to 3.7] 7/148 (4.7) [1.9 to 9.5] 0.78 0.11 0.14
 Perforation 6/604 (1.0) [0.4 to 2.1] 14/773 (1.8) [1.0 to 3.0] 2/148 (1.4) [0.2 to 4.8] 0.21 0.71 0.69
 Abrupt closure 4/604 (0.7) [0.2 to 1.7] 13/773 (1.7) [0.9 to 2.9] 3/148 (2.0) [0.4 to 5.8] 0.10 0.14 0.77
 Distal embolization 27/599 (4.5) [3.0 to 6.5] 41/775 (5.3) [3.8 to 7.1] 8/144 (5.6) [2.4 to 10.7] 0.60 0.72 0.96

Abbreviation: RC, Rutherford category.

a

Data are presented as the number/sample (percentage) [95% confidence interval].

b

Number of subjects/lesions with data available for core laboratory analysis, unless otherwise noted.